- External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma
-
Lee JY, Chung YS, Na K, Kim HM, Park CK, Nam EJ, Kim S, Kim SW, Kim YT, Kim HS
- KMID: 2413200
- J Gynecol Oncol.
- 2017 Nov;28(6):e73.
- doi: 10.3802/jgo.2017.28.e73
OBJECTIVE: The chemotherapy response score (CRS) system based on histopathological examination has been recently proposed for tubo-ovarian high-grade serous carcinoma (HGSC) to assess response to neoadjuvant chemotherapy (NAC). This study... -
- CITED
-
- Close
- SHARE
-
- Close
